Argeris N Karabelas - Net Worth and Insider Trading

Argeris N Karabelas Net Worth

The estimated net worth of Argeris N Karabelas is at least $246,546 dollars as of 2024-12-27. Argeris N Karabelas is the Director of Bausch Health Companies Inc and owns about 20,726 shares of Bausch Health Companies Inc (BHC) stock worth over $157,725. Argeris N Karabelas is the Director of Regenxbio Inc and owns about 11,286 shares of Regenxbio Inc (RGNX) stock worth over $88,821. Argeris N Karabelas is also the Director of Vanda Pharmaceuticals Inc and owns about 0 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $0. Details can be seen in Argeris N Karabelas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Argeris N Karabelas has not made any transactions after 2024-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Argeris N Karabelas

To

Argeris N Karabelas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Argeris N Karabelas owns 5 companies in total, including Regenxbio Inc (RGNX) , Bausch Health Companies Inc (BHC) , and Rocket Pharmaceuticals Inc (RCKT) among others .

Click here to see the complete history of Argeris N Karabelas’s form 4 insider trades.

Insider Ownership Summary of Argeris N Karabelas

Ticker Comapny Transaction Date Type of Owner
RGNX Regenxbio Inc 2024-10-01 director
BHC Bausch Health Companies Inc 2017-05-05 director
RCKT Rocket Pharmaceuticals Inc 2015-02-17 director & 10 percent owner
LIMIT LIMIT 2010-03-12 director & Chairman of the Board
LIMIT LIMIT 2009-07-23 other: See remarks below.

Argeris N Karabelas Latest Holdings Summary

Argeris N Karabelas currently owns a total of 3 stocks. Among these stocks, Argeris N Karabelas owns 20,726 shares of Bausch Health Companies Inc (BHC) as of August 11, 2016, with a value of $157,725 and a weighting of 63.97%. Argeris N Karabelas owns 11,286 shares of Regenxbio Inc (RGNX) as of October 1, 2024, with a value of $88,821 and a weighting of 36.03%. Argeris N Karabelas also owns 0 shares of Vanda Pharmaceuticals Inc (VNDA) as of March 12, 2010, with a value of $0 and a weighting of 0%.

Latest Holdings of Argeris N Karabelas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHC Bausch Health Companies Inc 2016-08-11 20,726 7.61 157,725
RGNX Regenxbio Inc 2024-10-01 11,286 7.87 88,821
VNDA Vanda Pharmaceuticals Inc 2010-03-12 0 4.81 0

Holding Weightings of Argeris N Karabelas


Argeris N Karabelas Form 4 Trading Tracker

According to the SEC Form 4 filings, Argeris N Karabelas has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the acquisition of 4,000 shares on August 11, 2016, which cost Argeris N Karabelas around $98,600.

According to the SEC Form 4 filings, Argeris N Karabelas has made a total of 5 transactions in Regenxbio Inc (RGNX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Regenxbio Inc is the sale of 10,000 shares on October 1, 2024, which brought Argeris N Karabelas around $101,100.

According to the SEC Form 4 filings, Argeris N Karabelas has made a total of 0 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 200,000 shares on March 12, 2010, which brought Argeris N Karabelas around $2 Million.

Insider Trading History of Argeris N Karabelas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Argeris N Karabelas Trading Performance

GuruFocus tracks the stock performance after each of Argeris N Karabelas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Argeris N Karabelas is -26.5%. GuruFocus also compares Argeris N Karabelas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Argeris N Karabelas within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Argeris N Karabelas's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Argeris N Karabelas

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.58 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 17.23 LIMIT LIMIT LIMIT LIMIT LIMIT

Argeris N Karabelas Ownership Network

Ownership Network List of Argeris N Karabelas

No Data

Ownership Network Relation of Argeris N Karabelas

Insider Network Chart

Argeris N Karabelas Owned Company Details

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Argeris N Karabelas is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Argeris N Karabelas made 5 insider transaction in Regenxbio Inc (RGNX) with a net sale of 51,100. Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 9,748 shares made by Curran Simpson , and a net sale of 12,878 shares made by Steve Pakola .

In summary, during the past 3 months, insiders sold 10,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenxbio Inc Insider Transactions

No Available Data

Argeris N Karabelas Mailing Address

Above is the net worth, insider trading, and ownership report for Argeris N Karabelas. Currently GuruFocus does not have mailing address information for Argeris N Karabelas.

Discussions on Argeris N Karabelas

No discussions yet.